#news #biotech EHA: Epizyme’s first-in-class multiple myeloma drug candidate inhibits tumors in mice

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: EHA: Epizyme’s first-in-class multiple myeloma drug candidate inhibits tumors in mice .EHA: Epizyme’s first-in-class multiple myeloma drug candidate inhibits tumors in mice
aliu
Mon, 06/14/2021 – 05:39

from FierceBiotech: Biotech https://ift.tt/3iDZurq